XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

1 - 10 of 109 search results for !padrenullquery -UclCommunicationType:"announcement" UclOrgUnit:"cancer institute"

Results

  1. Immune cell discovery opens door to new powerful cancer therapies |…

    https://www.ucl.ac.uk/cancer/news/2020/jan/immune-cell-discovery-opens-door-new-powerful-cancer-therapies

    7 Jan 2020: Scientists at UCL have identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.

    Scientists at UCL have identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.

  2. Opinion: Prostate cancer screening 'in sight' | UCL Cancer Institute…

    https://www.ucl.ac.uk/cancer/news/2019/dec/opinion-prostate-cancer-screening-sight

    19 Dec 2019: Professor Mark Emberton, Dean of the Faculty of Medical Sciences, writes about the new UCL-led trial, which is testing to see if MRI scans could be effective at screening men for prostate cancer, in a similar way to how mammograms are used to check

    Professor Mark Emberton, Dean of the Faculty of Medical Sciences, writes about the new UCL-led trial, which is testing to see if MRI scans could be effective at screening men for prostate cancer, in a similar way to how mammograms are used to check

  3. One dose of radiotherapy as effective as five doses for cancer in the …

    https://www.ucl.ac.uk/cancer/news/2019/dec/one-dose-radiotherapy-effective-five-doses-cancer-spine

    3 Dec 2019: A single dose of radiotherapy is as “effective” as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

    A single dose of radiotherapy is as “effective” as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

  4. Next generation of cancer drugs focus of new Japanese partnership |…

    https://www.ucl.ac.uk/cancer/news/2019/nov/next-generation-cancer-drugs-focus-new-japanese-partnership

    25 Nov 2019: Researchers at UCL will lead groundbreaking cancer research which aims to identify vulnerabilities resulting from mutated DNA in cancers, as part of a new international drug target discovery alliance.

    Researchers at UCL will lead groundbreaking cancer research which aims to identify vulnerabilities resulting from mutated DNA in cancers, as part of a new international drug target discovery alliance.

  5. UCL and UCLH receive major investment to support next-generation…

    https://www.ucl.ac.uk/cancer/news/2019/nov/ucl-and-uclh-receive-major-investment-support-next-generation-radiotherapy-research

    4 Nov 2019: UCL, UCLH and other London partners will receive a £14 million investment from Cancer Research UK (CRUK) to develop techniques to improve radiotherapy.

    UCL, UCLH and other London partners will receive a £14 million investment from Cancer Research UK (CRUK) to develop techniques to improve radiotherapy.

  6. Detecting the (almost) undetectable: new cancer alliance | UCL Cancer …

    https://www.ucl.ac.uk/cancer/news/2019/oct/detecting-almost-undetectable-new-cancer-alliance

    21 Oct 2019: UCL research teams are part of a new transatlantic research alliance to develop radical new strategies and technologies to detect cancer at its earliest stage.

    UCL research teams are part of a new transatlantic research alliance to develop radical new strategies and technologies to detect cancer at its earliest stage.

  7. Athena SWAN Silver Award success | UCL Cancer Institute - UCL -…

    https://www.ucl.ac.uk/cancer/news/2019/oct/athena-swan-silver-award-success

    10 Oct 2019: UCL Cancer Institute has successfully renewed its Athena SWAN Silver status in recognition of our commitment to equality, diversity and inclusion.

    UCL Cancer Institute has successfully renewed its Athena SWAN Silver status in recognition of our commitment to equality, diversity and inclusion.

  8. Secrets of lung cancer spread found in patients’ blood and biopsies | …

    https://www.ucl.ac.uk/cancer/news/2019/oct/secrets-lung-cancer-spread-found-patients-blood-and-biopsies

    8 Oct 2019: Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a trio of papers co-led by UCL.

    Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a trio of papers co-led by UCL.

  9. Method discovered to reactivate tumour fighting genes ‘silenced’ by…

    https://www.ucl.ac.uk/cancer/news/2019/sep/method-discovered-reactivate-tumour-fighting-genes-silenced-cancer

    27 Sep 2019: Scientists at UCL have developed a method to reactivate ‘tumour suppressor’ genes, which are switched off by cancer cells – a finding which could lead to new targeted biotherapies for cancer.

    Scientists at UCL have developed a method to reactivate ‘tumour suppressor’ genes, which are switched off by cancer cells – a finding which could lead to new targeted biotherapies for cancer.

  10. New CAR T-cell therapy for leukaemia associated with fewer harmful…

    https://www.ucl.ac.uk/cancer/news/2019/sep/new-car-t-cell-therapy-leukaemia-associated-fewer-harmful-side-effects

    7 Sep 2019: A novel CAR T-cell therapy, developed by UCL researchers and designed to target cancer cells more quickly and cause fewer side effects, has shown very promising results for children with previously incurable acute lymphoblastic leukaemia (ALL).

    A novel CAR T-cell therapy, developed by UCL researchers and designed to target cancer cells more quickly and cause fewer side effects, has shown very promising results for children with previously incurable acute lymphoblastic leukaemia (ALL).

Pagination

Refine

Subjects

Organisational Units

Communication types

Audiences